• 1. Market Access Solution

    a. Market Intelligence and strategic consultancy
    b. Pre and post launch strategies
    c. Pricing and Reimbursement
    d. KOL Management
    e. Advisory boards and expert panels
  • 2. Regulatory Consultancy

    a. Named Patient Use Policy
    b. Expanded Access Program Management
    c. Orphan Drug Regulations
    d. Communication with Authorities
    e. Registration, Pricing and reimbursement
  • 3. Medical education and training programs

    a. Medico-Marketing Trainings
    b. Pharmacovigilence Trainings
    c. Good Clinical Practice(GCP) and Observational Research Trainings
  • 4. Observational Research and Registries

    a. Observational Study Synopsis, Protocol, Informed Consent Form (ICF),
    b. Case Report Form (CRF), E-CRF Design
    c. Observational Study Ethics Committee and Authority Approvals
    d. Observational Study Monitoring
    e. Investigators’ and Site Contracts And Payments
    f. Observational Study Report Preparation
    g. Data Management And Biostatistics
    h. Translation and Cultural Adaptation Of Essential and Other Study Documentation
  • 5. Pharmacovigilance